Exhibitors
Ambu
Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anesthesia and patient monitoring solutions.
We are driven by our strong purpose:
Together, we rethink solutions to save lives and improve patient care.
We are the market leader in single-use endoscopy, a market we created in 2009 with the world’s first single-use bronchoscope, the Ambu® aScopeTM.
Today, we have expanded our presence across the four major endoscopy segments – pulmonology, ENT (ear-nose-throat), urology and, most recently, GI (gastroenterology).
We keep disrupting the global healthcare industry with smarter and simpler solutions that break down conventional barriers for hospitals and clinics.
Our commitment to our customers is unwavering. We deliver innovations that make a real difference to healthcare professionals and their patients by collaborating with leading medical experts to uncover their needs in depth.
We listen, and we learn. And we translate those needs into solutions that activate the future.
Castle Biosciences
Castle Biosciences is a leading diagnostics company improving health through innovative tests that guide patient care. We aim to transform disease management by keeping patients and clinicians first. Our innovative tests for skin cancers, uveal melanoma, Barrett’s esophagus and mental health conditions provide personalized, clinically actionable information to clinicians and patients to guide treatment decisions and improve health outcomes. (www.CastleTestInfo.com).
ConMed
CONMED is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients.
With products that are recognized as technological leaders by the specialties they serve, healthcare professionals within the Orthopedic, Laparoscopic, Robotic & Open Surgery, Gastroenterology & Pulmonology and Cardiology & Critical Care specialties have come to value the CONMED name across the world.
Our Mission is to enable healthcare providers around the world to deliver exceptional outcomes for patients, through accessible CONMED solutions.
At CONMED our passion and responsibility is for the success of our customers and the patients for whom they care.
Cook Medical Endoscopy
Since 1963, Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we invent, manufacture and deliver a unique portfolio of medical devices to the healthcare systems of the world. Serving patients is a privilege, and we demand the highest standards of quality, ethics and service. We have remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities.
Cyted Health
Cyted Health is a company with extensive expertise and experience with innovative approaches to detect Esophageal Adenocarcinoma (EAC) and its precursor, Barrett’s Esophagus (BE).
The company’s minimally-invasive, non-endoscopic diagnostic platform has been validated through 10 years of clinical research and more than 26,000 patients tested in real-world clinical use since 2020.
We are introducing two advanced NGS-based* genomic assays coupled with our FDA 510(k) cleared, minimally-invasive EndoSign® capsule sponge cell collection device to enable the early detection, diagnosis and characterization of BE and neoplasia including EAC.
With the overriding goal of reducing the morbidity and mortality associated with EAC, Cyted Health’s mission is to develop improved clinical and diagnostic tools that enable early disease detection and intervention.
Cyted Health
Cyted Health is a company with extensive expertise and experience with innovative approaches to detect Esophageal Adenocarcinoma (EAC) and its precursor, Barrett’s Esophagus (BE).
The company’s minimally-invasive, non-endoscopic diagnostic platform has been validated through 10 years of clinical research and more than 26,000 patients tested in real-world clinical use since 2020.
We are introducing two advanced NGS-based* genomic assays coupled with our FDA 510(k) cleared, minimally-invasive EndoSign® capsule sponge cell collection device to enable the early detection, diagnosis and characterization of BE and neoplasia including EAC.
With the overriding goal of reducing the morbidity and mortality associated with EAC, Cyted Health’s mission is to develop improved clinical and diagnostic tools that enable early disease detection and intervention
Diversatek Healthcare
At Diversatek Healthcare, we’re dedicated to expanding our comprehensive range of diagnostic and therapeutic GI applications – all to help you provide exceptional patient care.
Science, technology and an untiring commitment to GI Care. It’s in everything we do.
Gastro Concepts
Gastro Concepts is a team of a gastroenterologists and engineers, dedicated to finding improvements and enhancing the safety and efficacy in the field of Gastroenterology.
Our flagship product, the Air Assist, is a novel device for colonoscopy, that prevents air/CO2 escape and maintains colonic distension, resulting in more efficient and less frustrating colonoscopies. It is the product of a practicing gastroenterologist with extensive endoscopic experience, who after years of performing thousands of colonoscopies, found a simple safe solution to a common problem. We feel that it is a solution that will enhance the colonoscopy experience for both the endoscopist and endoscopy staff.
Magentiq Eye LTD
Magentiq Eye Ltd., ISO 13485:2016 certified company, was established in 2014 with the aim to harness the most cutting edge computer vision and deep learning techniques to aid doctors in endoscopic procedures. Doctors today spend hours during Endoscopic Procedures looking at the LCD screens in order to explore, examine and treat various conditions. At Magentiq Eye we put the growing power of Deep Learning, Image and Video Processing to the help of doctors, so they can be more accurate and effective - ultimately saving millions of lives and billions of dollars. Our first product is MAGENTIQ-COLO™, which is used to increase the polyp (Adenoma) detection rate and the performance in the colonoscopy examination, is a real-time device adjunct to the colonoscopy device.
Mallinckrodt Pharmaceuticals
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Ovesco Endoscopy USA
Ovesco Endoscopy has been created by a group of scientists and clinicians leveraging their knowledge and research assets in the field of advanced endoscopic and surgical procedures in the gastrointestinal tract.
Our core competence is to invent endoluminal procedures and technologies that provide significant advantage to patients and clinicians in the field of gastrointestinal diseases. Our employees strive to develop and market products of outstanding quality and customer benefit.
We develop, manufacture and market instruments and systems for the treatment of gastrointestinal diseases. We offer comprehensive procedures, not only products, and support you all the way from training to intervention.
Ovesco’s hallmark are innovative endoscopic clipping systems. The OTSC® is our product platform for the treatment of gastrointestinal hemorrhage and for endoscopic digestive organ wall closure. Our clip technology forms a solid basis for many other procedures. Over the years, our portfolio has been expanded by novel resection techniques, such as FTRD® and RESECT+.
Our headquarters is based in Tuebingen, Germany. Furthermore, Ovesco has locations in France and the USA. Patients are treated with Ovesco products in over 70 countries worldwide.
Regeneron Pharmaceuticals Inc
Exhibitor Registration